Novo Nordisk, Europe’s largest company by market value, faced a stock market bloodbath on Friday after disappointing results ...
Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.
Shares in Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, plunged ...
The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's popular diabetes ...
Shares in Ozempic maker Novo Nordisk crashed, after an experimental anti-obesity shot fell short of expectations. The shares ...
New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way ...
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...
Ozempic manufacturer Novo Nordisk said patient safety is a priority and “the benefit-risk profile of semaglutide remains ...
Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two ...
According to its website, Novo Nordisk was founded in 1923 in Copenhagen, Denmark’s capital city. It is best known for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback